Clinical and Biochemical Factors Associated with Infliximab Pharmacokinetics in Paediatric Patients with Inflammatory Bowel Disease.

J Clin Med · 2025 · PMC11818818 · PMID 39941516

Europe PMC DOI

hedged sentence

0.0650

closest p · 1.3× alpha

0.0650

boldest claim

The sentences

did not reach statistical significancep = 0.065so close (0.05 < p ≤ 0.1)

showed that adults not taking concurrent immunosuppressive therapy such as AZA or MTX had lower IFX levels (median 2.42 μg/mL) compared to those taking immunosuppressive therapy (median 6.45 μg/mL), although this difference did not reach statistical significance ( p = 0.065) [ 56 ].

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.